Visceral adiposity index levels in overweight and/or obese, and non-obese patients with polycystic ovary syndrome and its relationship with metabolic and inflammatory parameters. (Q53761370)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Visceral adiposity index levels in overweight and/or obese, and non-obese patients with polycystic ovary syndrome and its relationship with metabolic and inflammatory parameters.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

19 May 2018

http://europepmc.org/abstract/MED/27838846

Visceral adiposity index levels in overweight and/or obese, and non-obese patients with polycystic ovary syndrome and its relationship with metabolic and inflammatory parameters. (English)

1 reference

Europe PubMed Central

19 May 2018

http://europepmc.org/abstract/MED/27838846

0 references

0 references

polycystic ovary syndrome

1 reference

based on heuristic

inferred from title

polycystic ovary

1 reference

based on heuristic

inferred from title

author name string

U Durmus

1

1 reference

Europe PubMed Central

19 May 2018

http://europepmc.org/abstract/MED/27838846

C Duran

2

1 reference

Europe PubMed Central

19 May 2018

http://europepmc.org/abstract/MED/27838846

S Ecirli

3

1 reference

Europe PubMed Central

19 May 2018

http://europepmc.org/abstract/MED/27838846

publication date

12 November 2016

1 reference

Europe PubMed Central

19 May 2018

http://europepmc.org/abstract/MED/27838846

Journal of Endocrinological Investigation

1 reference

Europe PubMed Central

19 May 2018

http://europepmc.org/abstract/MED/27838846

40

1 reference

Europe PubMed Central

19 May 2018

http://europepmc.org/abstract/MED/27838846

5

1 reference

Europe PubMed Central

19 May 2018

http://europepmc.org/abstract/MED/27838846

487-497

1 reference

Europe PubMed Central

19 May 2018

http://europepmc.org/abstract/MED/27838846

https://scigraph.springernature.com/pub.10.1007/s40618-016-0582-x

0 references

Obesity, type 2 diabetes mellitus and cardiovascular disease risk: an uptodate in the management of polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0582-X

21 January 2018

New markers of insulin resistance in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0582-X

21 January 2018

Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0582-X

21 January 2018

Global adiposity and thickness of intraperitoneal and mesenteric adipose tissue depots are increased in women with polycystic ovary syndrome (PCOS).

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0582-X

21 January 2018

Association of pericardial fat, intrathoracic fat, and visceral abdominal fat with cardiovascular disease burden: the Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0582-X

21 January 2018

The effect of obesity on polycystic ovary syndrome: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0582-X

21 January 2018

Comparison of regional fat mass measurement by whole body DXA scans and anthropometric measures to predict insulin resistance in women with polycystic ovary syndrome and controls.

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0582-X

21 January 2018

Body composition assessment for the definition of cardiometabolic risk.

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0582-X

21 January 2018

The metabolic syndrome: a global public health problem and a new definition

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0582-X

21 January 2018

Obesity, regional body fat distribution, and the metabolic syndrome in older men and women

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0582-X

21 January 2018

Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0582-X

21 January 2018

Does Visceral Fat Estimated by Dual-Energy X-ray Absorptiometry Independently Predict Cardiometabolic Risks in Adults?

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0582-X

21 January 2018

Visceral adiposity index: an indicator of adipose tissue dysfunction

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0582-X

21 January 2018

Visceral Adiposity Index: a reliable indicator of visceral fat function associated with cardiometabolic risk.

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0582-X

21 January 2018

Metabolically healthy polycystic ovary syndrome (MH-PCOS) and metabolically unhealthy polycystic ovary syndrome (MU-PCOS): a comparative analysis of four simple methods useful for metabolic assessment

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0582-X

21 January 2018

Visceral Adiposity Index Is Associated with Pre-Diabetes and Type 2 Diabetes Mellitus in Chinese Adults Aged 20-50.

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0582-X

21 January 2018

Visceral adiposity index and prognosis among patients with ischemic heart failure

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0582-X

21 January 2018

Comparison of visceral and body fat indices and anthropometric measures in relation to untreated hypertension by age and gender among Chinese

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0582-X

21 January 2018

Measures of body adiposity and visceral adiposity index as predictors of metabolic syndrome among Thai women with PCOS.

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0582-X

21 January 2018

The Visceral Adiposity Index in Comparison with Easily Measurable Anthropometric Markers Did Not Improve Prediction of Diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0582-X

21 January 2018

Surrogate markers of visceral adiposity in young adults: waist circumference and body mass index are more accurate than waist hip ratio, model of adipose distribution and visceral adiposity index

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0582-X

21 January 2018

Evaluation of hs-CRP and visseral adiposity index in patients with policystic ovary syndrome by clinical and laboratory findings.

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0582-X

21 January 2018

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0582-X

21 January 2018

Dyslipidaemia is associated with insulin resistance in women with polycystic ovaries.

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0582-X

21 January 2018

Cardiometabolic features of polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0582-X

21 January 2018

Cardiometabolic aspects of the polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0582-X

21 January 2018

Lipid levels in polycystic ovary syndrome: systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0582-X

21 January 2018

Determinants of dyslipidaemia in probands with polycystic ovary syndrome and their sisters

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0582-X

21 January 2018

Relation of Body Circumferences to Cardiometabolic Disease in Overweight-Obese Subjects

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0582-X

21 January 2018

The visceral adiposity index as a predictor of insulin resistance in young women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0582-X

21 January 2018

Metabolic syndrome and metabolic risk profile according to polycystic ovary syndrome phenotype

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0582-X

21 January 2018

Visceral adiposity index (VAI) is related to the severity of anovulation and other clinical features in women with polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0582-X

21 January 2018

Cut-off points of the visceral adiposity index (VAI) identifying a visceral adipose dysfunction associated with cardiometabolic risk in a Caucasian Sicilian population

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0582-X

21 January 2018

Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0582-X

21 January 2018

Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0582-X

21 January 2018

Insulin sensitivity, insulin secretion, and metabolic and hormonal parameters in healthy women and women with polycystic ovarian syndrome.

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0582-X

21 January 2018

Normal basal and insulin-stimulated fuel metabolism in lean women with the polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0582-X

21 January 2018

Visceral adiposity index and DHEAS are useful markers of diabetes risk in women with polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0582-X

21 January 2018

Evaluation of cardiac risk marker levels in obese and non-obese patients with polycystic ovaries

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0582-X

21 January 2018

Central fat excess in polycystic ovary syndrome: relation to low-grade inflammation and insulin resistance.

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0582-X

21 January 2018

Cardiovascular risk factors in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0582-X

21 January 2018

High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0582-X

21 January 2018

Visceral adiposity index (VAI) is predictive of an altered adipokine profile in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0582-X

21 January 2018

Normal serum uric acid concentrations in women with polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0582-X

21 January 2018

Serum uric acid concentration as non-classic cardiovascular risk factor in women with polycystic ovary syndrome: effect of treatment with ethinyl-estradiol plus cyproterone acetate versus metformin.

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0582-X

21 January 2018

Relative androgenicity, blood pressure levels, and cardiovascular risk factors in young healthy women.

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0582-X

21 January 2018

Comparison of various adiposity indexes in women with polycystic ovary syndrome and normo-ovulatory non-hirsute women: a population-based study

1 reference

https://pubmed.ncbi.nlm.nih.gov/27838846

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Polycystic ovary syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/27838846

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adipose Tissue Has Aberrant Morphology and Function in PCOS: Enlarged Adipocytes and Low Serum Adiponectin, But Not Circulating Sex Steroids, Are Strongly Associated with Insulin Resistance

1 reference

https://pubmed.ncbi.nlm.nih.gov/27838846

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhanced early insulin response to glucose in relation to insulin resistance in women with polycystic ovary syndrome and normal glucose tolerance

1 reference

https://pubmed.ncbi.nlm.nih.gov/27838846

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adipose tissue determinations in cadavers--a comparison between cross-sectional planimetry and computed tomography

1 reference

https://pubmed.ncbi.nlm.nih.gov/27838846

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hyperinsulinism and polycystic ovary syndrome (PCOS): role of insulin clearance

1 reference

https://pubmed.ncbi.nlm.nih.gov/27838846

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of insulin on uric acid excretion in humans.

1 reference

https://pubmed.ncbi.nlm.nih.gov/27838846

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey

1 reference

https://pubmed.ncbi.nlm.nih.gov/27838846

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma total oxidant and antioxidant status after oral glucose tolerance and mixed meal tests in patients with polycystic ovary syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/27838846

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predictive markers for abnormal glucose intolerance in women with polycystic ovary syndrome.

1 reference

https://pubmed.ncbi.nlm.nih.gov/27838846

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Healthy percentage body fat ranges: an approach for developing guidelines based on body mass index

1 reference

https://pubmed.ncbi.nlm.nih.gov/27838846

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insulin resistance and endocrine-metabolic abnormalities in polycystic ovarian syndrome: Comparison between obese and non-obese PCOS patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/27838846

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impaired glucose tolerance is associated with changes in clinical and biochemical parameters in women with polycystic ovary syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/27838846

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The oligomenorrhoic phenotypes of polycystic ovary syndrome are characterized by a high visceral adiposity index: a likely condition of cardiometabolic risk

1 reference

https://pubmed.ncbi.nlm.nih.gov/27838846

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S40618-016-0582-X

1 reference

Europe PubMed Central

19 May 2018

http://europepmc.org/abstract/MED/27838846

1 reference

Europe PubMed Central

19 May 2018

http://europepmc.org/abstract/MED/27838846

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53761370&oldid=1588357808"